"
Team:Uppsala/advisors
From 2013.igem.org
| (8 intermediate revisions not shown) | |||
| Line 13: | Line 13: | ||
</style> | </style> | ||
| + | |||
| + | <script type="text/javascript"> | ||
| + | /*Acts once the document is loaded*/ $(document).ready(function() { /*Move the tn-main-wrap as child of <body>*/ $("#tn-main-wrap-wrap").prependTo($("body")); /*Move the menubars in the tn-main-wrap*/ $("#menubar.left-menu").appendTo($("#tn-main-wrap")); $("#menubar.right-menu").appendTo($("#tn-main-wrap")); | ||
| + | /*Spoiler JS*/ $(".tn-spoiler div").slideUp(); $(".tn-spoiler a").click(function(e) { e.preventDefault(); $(".tn-spoiler-active").removeClass("tn-spoiler-active"); $(this).parent().addClass("tn-spoiler-active"); $(".tn-spoiler").not(".tn-spoiler-active").children("div").slideUp(); $(".tn-spoiler-active").children("div").slideToggle(); }); | ||
| + | /*Add favicon*/ $("link[rel='shortcut icon']").remove(); $("head").append("<link rel='shortcut icon' type='image/png' href='https://static.igem.org/mediawiki/2013/6/6d/Uppsalas-cow-con.png'>"); }); | ||
| + | </script> | ||
</head> | </head> | ||
| Line 57: | Line 63: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a> | <li><a href="https://2013.igem.org/Team:Uppsala/metabolic-engineering">Metabolic engineering</a> | ||
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid"> | + | <li><a href="https://2013.igem.org/Team:Uppsala/p-coumaric-acid">p-Coumaric acid</a></li> |
<li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/resveratrol">Resveratrol</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/lycopene">Lycopene</a></li> | ||
| Line 78: | Line 84: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a> | <li><a href="https://2013.igem.org/Team:Uppsala/modeling" id="list_type1"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/6/63/Uppsala2013_Modeling.png"></a> | ||
<ul> | <ul> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway"> | + | <li><a href="https://2013.igem.org/Team:Uppsala/P-Coumaric-acid-pathway">Kinetic model</a></li> |
<li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/modeling-tutorial">Modeling tutorial </a></li> | ||
| + | |||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/toxicity-model">Toxicity model</a></li> | ||
</ul></li> | </ul></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/parts" id="list_type2"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/e/eb/Uppsala2013_parts.png"></a></li> | ||
| Line 88: | Line 96: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/carotenoid-group">Carotenoid group</a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/chassi-group">Chassi group</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/advisors">Advisors</a></li> | ||
</ul></li> | </ul></li> | ||
| Line 97: | Line 106: | ||
<li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/public-opinion">Public opinion </a></li> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/Outreach">High school & media </a></li> | ||
| - | + | <li><a href="https://2013.igem.org/Team:Uppsala/bioart">BioArt</a></li> | |
| + | <li><a href="https://2013.igem.org/Team:Uppsala/LactonutritiousWorld">A LactoWorld</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/killswitches">Killswitches</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/realization">Patent</a></li> | ||
</ul></li> | </ul></li> | ||
| - | <li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a | + | <li><a href="https://2013.igem.org/Team:Uppsala/attribution" id="list_type4"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/5/5d/Uppsala2013_Attributions.png"></a></li> |
| - | + | ||
| - | + | ||
| - | + | ||
<li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a> | <li><a href="https://2013.igem.org/Team:Uppsala/notebook" id="list_type3"><img class="nav-text" src="https://static.igem.org/mediawiki/2013/3/36/Uppsala2013_Notebook.png"></a> | ||
<ul> | <ul> | ||
<li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li> | <li><a href="https://2013.igem.org/Team:Uppsala/safety-form">Safety form</a></li> | ||
| + | <li><a href="https://2013.igem.org/Team:Uppsala/protocols">Protocols</a></li> | ||
</ul></li> | </ul></li> | ||
</ul> | </ul> | ||
| Line 125: | Line 135: | ||
<div id="text-box1"> | <div id="text-box1"> | ||
<h1>Anders Virtanen</h1> | <h1>Anders Virtanen</h1> | ||
| - | <p>Anders Virtanen is a professor at the Department of Cell and Molecular Biology and the director of the Uppsala RNA Research Centre (URRC). Anders studies primarily enzymes involved in regulating fate and function of the | + | <p>Anders Virtanen is a professor at the Department of Cell and Molecular Biology and the director of the Uppsala RNA Research Centre (URRC). Anders studies primarily enzymes involved in regulating fate and function of the plethora of RNA molecules in the cell. Another goal is to develop novel antibiotics targeting RNA molecules.</p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 163: | Line 173: | ||
<div id="text-box"> | <div id="text-box"> | ||
| - | <h1> | + | <h1> Abhishek Srivastava </h1> |
<p>Postdoc at Chemical Biology Group, Department of Cell | <p>Postdoc at Chemical Biology Group, Department of Cell | ||
and Molecular biology, at Uppsala University since 2012 and is | and Molecular biology, at Uppsala University since 2012 and is | ||
| Line 178: | Line 188: | ||
<div id="left"> | <div id="left"> | ||
| - | <img class="pic" src="https://static.igem.org/mediawiki/2013/ | + | <img class="pic" src="https://static.igem.org/mediawiki/2013/1/17/Uppsala2013_roos.jpg"> |
<div id="text-box"> | <div id="text-box"> | ||
| Line 188: | Line 198: | ||
<div id="right"> | <div id="right"> | ||
| - | <img class="pic" src="https://static.igem.org/mediawiki/2013/ | + | <img class="pic" src="https://static.igem.org/mediawiki/2013/0/02/Uppsala2013_sethu.jpg"> |
<div id="text-box"> | <div id="text-box"> | ||
| - | <h1>Sethu</h1> | + | <h1> Sethu Madhava Rao Gunja </h1> |
<p>Research Assistant at Chemical Biology group, Department of Cell and Molecular Biology in Uppsala University since 2012 and is currently working on Physiological characterisation of human enzyme Poly(A)-specific ribonuclease (PARN) in the Anders Virtanen group at the Uppsala Biomedical Center.</p> | <p>Research Assistant at Chemical Biology group, Department of Cell and Molecular Biology in Uppsala University since 2012 and is currently working on Physiological characterisation of human enzyme Poly(A)-specific ribonuclease (PARN) in the Anders Virtanen group at the Uppsala Biomedical Center.</p> | ||
</div> | </div> | ||
| Line 217: | Line 227: | ||
<div id="text-box"> | <div id="text-box"> | ||
<h1>Erik Lundin</h1> | <h1>Erik Lundin</h1> | ||
| - | <p>PhD student in Medical Bacteriology at the Department of Medical Biochemistry and Microbiology at Uppsala University since 2013. Erik Lundin is currently working on bacterial evolution where he studies | + | <p>PhD student in Medical Bacteriology at the Department of Medical Biochemistry and Microbiology at Uppsala University since 2013. Erik Lundin is currently working on bacterial evolution where he studies evolution of new genes and functions. Erik works in Dan Andersson group at the Uppsala Biomedical Center. </p> |
</div> | </div> | ||
</div> | </div> | ||
| Line 227: | Line 237: | ||
</div> | </div> | ||
| + | |||
| + | <div id="gunnar"> | ||
| + | |||
| + | <img class="gunnar-pic" src="https://static.igem.org/mediawiki/2013/7/7f/Uppsala2013_gunnar.jpg"> | ||
| + | <h1>Gunnar Johannson</h1> | ||
| + | <p>Gunnar Johansson is professor in Biochemistry at Uppsala university. His | ||
| + | research is focused on enzyme nanotechnology and sustainable materials | ||
| + | technology based on biomass.</p> | ||
| + | |||
| + | </div> | ||
<div id="bottom-pic"> | <div id="bottom-pic"> | ||
Latest revision as of 17:47, 28 October 2013
Supervisors
Anders Virtanen
Anders Virtanen is a professor at the Department of Cell and Molecular Biology and the director of the Uppsala RNA Research Centre (URRC). Anders studies primarily enzymes involved in regulating fate and function of the plethora of RNA molecules in the cell. Another goal is to develop novel antibiotics targeting RNA molecules.
Anthony Forster
Anthony Forster is a professor at the Department of Cell and Molecular Biology and a member of the Uppsala RNA Research Centre (URRC). He is researching synthetic biology, protein synthesis and drug discovery, and is currently working towards the synthesis of a minimal cell.
Instructors
Mikael Nissbeck
PhD student at Uppsala RNA Research Center (URRC), Department of Cell and Molecular biology, at Uppsala University since 2012 and is currently working on the human enzyme Poly(A)-specific ribonuclease (PARN) in the Anders Virtanen group at the Uppsala Biomedical Center.
Abhishek Srivastava
Postdoc at Chemical Biology Group, Department of Cell and Molecular biology, at Uppsala University since 2012 and is currently working on ribonuclease P in Leif Kirsebom group at the Uppsala Biomedical Center.
Stefan Roos
Stefan Roos is an associate professor at the Department of Microbiology at Swedish University of Agricultural Sciences in Uppsala. Stefan works with genomics, physiology and ecology of probiotic lactobacilli. The primary goals are to understand how those bacteria interact with their host and to design probiotic products with improved activity.
Sethu Madhava Rao Gunja
Research Assistant at Chemical Biology group, Department of Cell and Molecular Biology in Uppsala University since 2012 and is currently working on Physiological characterisation of human enzyme Poly(A)-specific ribonuclease (PARN) in the Anders Virtanen group at the Uppsala Biomedical Center.
Erik Gullberg
PhD student in Medical Bacteriology at the Department of Medical Biochemistry and Microbiology at Uppsala University since 2009 and is currently working on antibiotic resistance in bacteria in the Dan Andersson group at the Uppsala Biomedical Center. So far he has published articles in PLoS Pathogens and Molecular Microbiology.
Erik Lundin
PhD student in Medical Bacteriology at the Department of Medical Biochemistry and Microbiology at Uppsala University since 2013. Erik Lundin is currently working on bacterial evolution where he studies evolution of new genes and functions. Erik works in Dan Andersson group at the Uppsala Biomedical Center.
Gunnar Johannson
Gunnar Johansson is professor in Biochemistry at Uppsala university. His research is focused on enzyme nanotechnology and sustainable materials technology based on biomass.
